尿:COVID-19

Tushar Sehgal1, Ambika Anand1, Gowtham Vijayabupathy1

  • 1Laboratory Medicine, All India Institute of Medical Sciences, New Delhi, New Delhi, IND.

Cureus
|December 26, 2024
PubMed
概括

溶性泌尿酸酶等离子体激活受体 (suPAR) 是COVID-19患者的显著预后指标. 住院患者中较高的suPAR水平预测死亡风险增加,有助于临床结果评估.